MedTrace Logo

A Study Evaluating the Safety of the Nasal Pump

NCT06329687 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2025-05-02

Study results available
· View outcomes & findings →

Summary

The objective of this study is to determine the safety of the Tyrvaya nasal pump.

Conditions

  • Dry Eye
  • Kerato Conjunctivitis Sicca

Interventions

DRUG

Tyrvaya Nasal Pump

Tyrvaya Nasal Pump with Silicone Lubricant

Sponsors & Collaborators

  • Oyster Point Pharma, Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-21
Primary Completion
2024-02-28
Completion
2024-02-28
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06329687 on ClinicalTrials.gov